Activity Refinement and Property Assessment of Peptidomimetics with Potent Antimalarial Activity That Target Plasmepsin V
- 15 August 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 12 (9) , 3114-3126
Abstract
Plasmepsin V is an essential aspartyl protease that cleaves the Plasmodium export element in proteins targeted for export from Plasmodium parasites into the host red blood cell. Substrate-mimicking peptidomimetics have been developed that potently inhibit plasmepsin V but show modest parasite activity. To advance these inhibitors, we optimized their potency by introducing a 2-chloro aryl group at P2 and an N-terminal sulfonamide that yielded WM960, which showed markedly improved plasmepsin V inhibition while retaining high selectivity over plasmepsin IX and X and human aspartyl proteases. WM960 also demonstrated enhanced activity against asexual blood-stage parasites and effectively suppressed protein export. However, WM960 displayed low metabolic stability and limited systemic exposure in mice, highlighting the need to improve pharmacokinetic properties in future development of peptidomimetic plasmepsin V targeted antimalarials.Keywords
Funding Information
- National Health and Medical Research Council (GNT1176955)
- Wellcome Trust (109662/Z/15/Z)
- Wellcome Trust (202749/Z/16/Z)
- University of Melbourne
This publication has 56 references indexed in Scilit:
- Plasmepsins as Antimalarial Drug Targets—Then, Now, and the FutureMedicinal Research Reviews, 2026
- MK-7602: a potent multi-stage dual-targeting antimalarialEBioMedicine, 2025
- Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CycleCell Host & Microbe, 2020
- Inhibition of Plasmepsin V Activity Blocks Plasmodium falciparum Gametocytogenesis and Transmission to MosquitoesCell Reports, 2019
- Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P 2 position of PEXEL peptidomimeticsEuropean Journal of Medicinal Chemistry, 2018
- Plasmodium berghei plasmepsin VIII is essential for sporozoite gliding motilityInternational Journal for Parasitology, 2017
- Exploration of the P3 region of PEXEL peptidomimetics leads to a potent inhibitor of the Plasmodium protease, plasmepsin VBioorganic & Medicinal Chemistry, 2016
- N-terminal processing of proteins exported by malaria parasitesMolecular and Biochemical Parasitology, 2008
- Exported Proteins Required for Virulence and Rigidity of Plasmodium falciparum-Infected Human ErythrocytesCell, 2008
- Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparumInternational Journal for Parasitology, 2007